These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19154630)

  • 41. The supramammillo-septal-hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats.
    Ma J; Leung LS
    Psychopharmacology (Berl); 2007 May; 191(4):961-74. PubMed ID: 17219218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
    Dall'Igna OP; Da Silva AL; Dietrich MO; Hoffmann A; de Oliveira RV; Souza DO; Lara DR
    Psychopharmacology (Berl); 2003 Mar; 166(3):258-63. PubMed ID: 12589526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detrimental effect of postnatal blockade of N-methyl-D-aspartate receptors on sensorimotor gating is reversed by neuroleptic drugs.
    Wedzony K; Fijał K; Maćkowiak M; Chocyk A
    Pharmacol Rep; 2008; 60(6):856-64. PubMed ID: 19211977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. D1 dopamine and NMDA receptors interactions in the medial prefrontal cortex: modulation of spatial working memory in rats.
    Rios Valentim SJ; Gontijo AV; Peres MD; Rodrigues LC; Nakamura-Palacios EM
    Behav Brain Res; 2009 Dec; 204(1):124-8. PubMed ID: 19482047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
    Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
    Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cocaine- and Amphetamine-Regulated Transcript Peptide (CART) Alleviates MK-801-Induced Schizophrenic Dementia-Like Symptoms.
    Borkar CD; Bharne AP; Nagalakshmi B; Sakharkar AJ; Subhedar NK; Kokare DM
    Neuroscience; 2018 Apr; 375():94-107. PubMed ID: 29425773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of atomoxetine and methylphenidate on the prepulse inhibition of the acoustic startle response in mice.
    Woo H; Park SJ; Lee Y; Kwon G; Gao Q; Lee HE; Ahn YJ; Shin CY; Cheong JH; Ryu JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():206-15. PubMed ID: 24953433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia.
    McLean SL; Idris NF; Woolley ML; Neill JC
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):440-50. PubMed ID: 19268547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preferential relocation of the N-methyl-D-aspartate receptor NR1 subunit in nucleus accumbens neurons that contain dopamine D1 receptors in rats showing an apomorphine-induced sensorimotor gating deficit.
    Hara Y; Pickel VM
    Neuroscience; 2008 Jun; 154(3):965-77. PubMed ID: 18479834
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GABAergic imbalance is normalized by dopamine D
    Gálvez-Rosas A; Avila-Luna A; Valdés-Flores M; Montes S; Bueno-Nava A
    Psychopharmacology (Berl); 2019 Jul; 236(7):2211-2222. PubMed ID: 30859334
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NC-1900, an arginine-vasopressin analogue, ameliorates social behavior deficits and hyperlocomotion in MK-801-treated rats: therapeutic implications for schizophrenia.
    Matsuoka T; Sumiyoshi T; Tanaka K; Tsunoda M; Uehara T; Itoh H; Kurachi M
    Brain Res; 2005 Aug; 1053(1-2):131-6. PubMed ID: 16051205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Swertisin ameliorates pre-pulse inhibition deficits and cognitive impairment induced by MK-801 in mice.
    Oh HK; Jeon SJ; Lee S; Lee HE; Kim E; Park SJ; Kim HN; Jung WY; Cheong JH; Jang DS; Ryu JH
    J Psychopharmacol; 2017 Feb; 31(2):250-259. PubMed ID: 27729563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The actions of a D-1 agonist in MPTP treated primates show dependence on both D-1 and D-2 receptor function and tolerance on repeated administration.
    Smith LA; Jackson MJ; Al-Barghouthy G; Jenner P
    J Neural Transm (Vienna); 2002 Feb; 109(2):123-40. PubMed ID: 12075853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the MK-801-induced increase in non-rewarded appetitive responding with dopamine agonists and locomotor activity in rats.
    Davis-MacNevin PL; Dekraker J; LaDouceur L; Holahan MR
    J Psychopharmacol; 2013 Sep; 27(9):854-64. PubMed ID: 23761388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The NMDA positive modulator D-cycloserine potentiates the neuroleptic activity of D1 and D2 dopamine receptor blockers in the rat.
    Dall'Olio R; Gandolfi O
    Psychopharmacology (Berl); 1993; 110(1-2):165-8. PubMed ID: 7870878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. D1 and D2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia.
    Hoffman DC; Donovan H
    Psychopharmacology (Berl); 1994 Aug; 115(4):447-53. PubMed ID: 7871088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors.
    Saklayen SS; Mabrouk OS; Pehek EA
    J Pharmacol Exp Ther; 2004 Oct; 311(1):342-8. PubMed ID: 15175419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats.
    Manahan-Vaughan D; von Haebler D; Winter C; Juckel G; Heinemann U
    Hippocampus; 2008; 18(2):125-34. PubMed ID: 17924525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of the H(3) antagonist, thioperamide, on behavioral alterations induced by systemic MK-801 administration in rats.
    Bardgett ME; Points M; Roflow J; Blankenship M; Griffith MS
    Psychopharmacology (Berl); 2009 Sep; 205(4):589-97. PubMed ID: 19466392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metformin reverses the schizophrenia-like behaviors induced by MK-801 in rats.
    Wang X; Luo C; Mao XY; Li X; Yin JY; Zhang W; Zhou HH; Liu ZQ
    Brain Res; 2019 Sep; 1719():30-39. PubMed ID: 31121159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.